Back
Astria Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
ATXS
Astria Therapeutics, Inc.
Last Price:
$13.01
Seasonality Move:
28.87%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATXS is experiencing slight buying pressure.
Astria Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.85 | Buy |
| 20-day SMA: | 12.83 | Buy |
| 50-day SMA: | 12.56 | Buy |
| 200-day SMA: | 7.64 | Buy |
| 8-day EMA: | 12.87 | Buy |
| 20-day EMA: | 12.77 | Buy |
| 50-day EMA: | 11.95 | Buy |
| 200-day EMA: | 9.23 | Buy |
Astria Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 62.47 | Buy |
| Chaikin Money Flow: | 79002 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.52 - 12.98) | Buy |
| Bollinger Bands (100): | (7.12 - 12.6) | Buy |
Astria Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Astria Therapeutics, Inc. Stock
Is Astria Therapeutics, Inc. Stock a Buy?
-
Astria Therapeutics, Inc. share price is 12.98 while ATXS 8-day simple moving average is 12.85, which is a Buy signal.
-
The stock price of ATXS is 12.98 while Astria Therapeutics, Inc. 20-day SMA is 12.83, which makes it a Buy.
-
Astria Therapeutics, Inc. 50-day simple moving average is 12.56 while ATXS share price is 12.98, making it a Buy technically.
-
ATXS stock price is 12.98 and Astria Therapeutics, Inc. 200-day simple moving average is 7.64, creating a Buy signal.
ATXS Technical Analysis vs Fundamental Analysis
Buy
56
Astria Therapeutics, Inc. (ATXS)
is a Buy
Is Astria Therapeutics, Inc. a Buy or a Sell?
-
Astria Therapeutics, Inc. stock is rated a BuyThe current Astria Therapeutics, Inc. [ATXS] share price is $12.98. The Score for ATXS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Astria Therapeutics, Inc. Stock Info
Market Cap:
741M
Price in USD:
12.98
Share Volume:
212.7K
Astria Therapeutics, Inc. 52-Week Range
52-Week High:
13.29
52-Week Low:
3.56
Buy
56
Astria Therapeutics, Inc. (ATXS)
is a Buy
Astria Therapeutics, Inc. Share Price Forecast
-
What is the Astria Therapeutics, Inc. stock price today?The Astria Therapeutics, Inc. stock price is 12.98 USD today.
-
Will ATXS stock go up or go down?Astria Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Astria Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Astria Therapeutics, Inc. is not overvalued.
Is Astria Therapeutics, Inc. Stock a Buy?
-
Astria Therapeutics, Inc. share price is 12.98 while ATXS 8-day exponential moving average is 12.87, which is a Buy signal.
-
The stock price of ATXS is 12.98 while Astria Therapeutics, Inc. 20-day EMA is 12.77, which makes it a Buy.
-
Astria Therapeutics, Inc. 50-day exponential moving average is 11.95 while ATXS share price is 12.98, making it a Buy technically.
-
ATXS stock price is 12.98 and Astria Therapeutics, Inc. 200-day simple moving average is 9.23, creating a Buy signal.
Fundamental Analysis of Astria Therapeutics, Inc.
Is Astria Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and a decrease next year of $0.23 per share.
Technical Analysis of Astria Therapeutics, Inc.
Should I short Astria Therapeutics, Inc. stock?
-
ATXS Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Astria Therapeutics, Inc. is a Buy
-
Astria Therapeutics, Inc. Relative Strength Index (RSI) is 62.47, which suggest Astria Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Astria Therapeutics, Inc. is (12.52 - 12.98), which suggest Astria Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Astria Therapeutics, Inc. is (7.12 - 12.6), which suggest Astria Therapeutics, Inc. is a Buy
* Astria Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.